Nintedanib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: Instructions Nintedanib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Nintedanib included in the composition |
Prices in pharmacies |
Vargatef | 862.9€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 49% Lorlatinib
- 44% Trametinib
- 35% Ramucirumab
- 33% Abemaciclib
- 32% Pirfenidone
- 31% Osimertinib
- 31% Afatinib
- 31% Ceritinib
- 30% Regorafenib
- 29% Orciprenaline
- 29% Sorafenib
- 29% Cabozantinib
- 26% Nivolumab
- 26% Vinorelbine
- 26% Topotecan
- 26% Atezolizumab
- 25% Palbociclib
- 23% Benzotef
- 23% Ibrutinib
- 23% Idarubicin
- 22% Ribociklib
- 22% Everolimus
- 22% Crizotinib
- 22% Vandetanib
- 21% Pazopanib
- 21% Gefitinib
- 21% Docetaxel
- 19% Isoprenaline
- 19% Pembrolizumab
- 19% Hydrazine sulfate
- 18% Bromhexine
- 18% Imatinib
- 18% Dasatinib
- 18% Vindesine
- 18% Nitrosomethylurea
- 18% Dornase alfa
- 18% Akalabrutinib
- 17% Gemcitabine
- 17% Nilotinib
- 17% Carubicin
- 16% Cobimetinib
- 16% Vemurafenib
- 16% Dabrafenib
- 16% Pemetrexed
- 16% Bosutinib
- 16% Proxifeine
- 15% Calcium pangamate
- 15% Interferon gamma human recombinant
- 15% Teniposide
- 14% Terbutaline
Learn more about the selection of analogues
- The drug has «Nintedanib» 51 analog by action, the most similar - Lorlatinib .
- Medical online service has selected the best substitutes for Nintedanib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Nintedanib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.